Remdesivir had received regulatory approvals or temporary authorisations to treat COVID-19 in approximately 50 countries including India. The drug has been pre-qualified by WHO. Post navigation Gold prices rise Rs 242 to Rs 50,905/10 gm, silver up Rs 1,399/kg Labour Ministry dismisses reports of new CPI-IW series leading to pay hike of employees